Lattuada, E., M. Lanzafame, C. Grosso, and F. Soldani, et al. “Optimal Fosamprenavir Regimen to Prevent Lipid Abnormalities”. Acta Biomedica Atenei Parmensis 80, no. 3 (December 1, 2009): 200–202. Accessed July 27, 2024. https://mattioli1885journals.com/index.php/actabiomedica/article/view/1171.